Medications for Familial Hypercholesterolemia Heterozygous

4 results

  • crestor

    (Rosuvastatin calcium)
    AstraZeneca Pharmaceuticals LP
    CRESTOR is indicated to reduce cardiovascular risk in adults without established coronary heart disease and to lower LDL-C levels in adults and pediatric patients with hyperlipidemia, including those with familial hypercholesterolemia. It is also used for treating primary dysbetalipoproteinemia and hypertriglyceridemia.

  • leqvio

    (inclisiran)
    Novartis Pharmaceuticals Corporation
    LEQVIO® is indicated as an adjunct to diet and statin therapy for adults with primary hyperlipidemia, including heterozygous familial hypercholesterolemia (HeFH), to reduce low-density lipoprotein cholesterol (LDL-C).

  • livalo

    (pitavastatin calcium)
    Kowa Pharmaceuticals America, Inc.
    LIVALO is indicated as an adjunct to diet for reducing low-density lipoprotein cholesterol (LDL-C) in adults with primary hyperlipidemia and in patients aged 8 years and older with heterozygous familial hypercholesterolemia (HeFH).

  • repatha

    (Evolocumab)
    Amgen Inc
    REPATHA is indicated for reducing the risk of myocardial infarction, stroke, and coronary revascularization in adults with established cardiovascular disease. It also reduces LDL-C in adults with primary hyperlipidemia, including HeFH, and in pediatric patients aged 10 and older with HeFH or HoFH as an adjunct to diet and other therapies.